» Articles » PMID: 37915134

Single-cell RNA Sequencing Reveals the Heterogeneity of Adipose Tissue-derived Mesenchymal Stem Cells Under Chondrogenic Induction

Overview
Journal BMB Rep
Date 2023 Nov 2
PMID 37915134
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated how adipose tissue-derived mesenchymal stem cells (AT-MSCs) respond to chondrogenic induction using droplet-based single-cell RNA sequencing (scRNA-seq). We analyzed 37,219 high-quality transcripts from control cells and cells induced for 1 week (1W) and 2 weeks (2W). Four distinct cell clusters (0-3), undetectable by bulk analysis, exhibited varying proportions. Cluster 1 dominated in control and 1W cells, whereas clusters (3, 2, and 0) exclusively dominated in control, 1W, and 2W cells, respectively. Furthermore, heterogeneous chondrogenic markers expression within clusters emerged. Gene ontology (GO) enrichment analysis of differentially expressed genes unveiled cluster-specific variations in key biological processes (BP): (1) Cluster 1 exhibited up-regulation of GO-BP terms related to ribosome biogenesis and translational control, crucial for maintaining stem cell properties and homeostasis; (2) Additionally, cluster 1 showed up-regulation of GO-BP terms associated with mitochondrial oxidative metabolism; (3) Cluster 3 displayed up-regulation of GO-BP terms related to cell proliferation; (4) Clusters 0 and 2 demonstrated similar up-regulation of GO-BP terms linked to collagen fibril organization and supramolecular fiber organization. However, only cluster 0 showed a significant decrease in GO-BP terms related to ribosome production, implying a potential correlation between ribosome regulation and the differentiation stages of AT-MSCs. Overall, our findings highlight heterogeneous cell clusters with varying balances between proliferation and differentiation before, and after, chondrogenic stimulation. This provides enhanced insights into the single-cell dynamics of AT-MSCs during chondrogenic differentiation. [BMB Reports 2024; 57(5): 232-237].

Citing Articles

Clinical outcome is unlinked to injection of adipose-derived regenerative cells in the axilla of breast cancer-related lymphedema patients.

Andersen D, Bjerre F, Jorgensen M, Sorensen J, Jensen C Stem Cell Res Ther. 2024; 15(1):426.

PMID: 39543743 PMC: 11566835. DOI: 10.1186/s13287-024-04037-z.


The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?.

Younesi F, Hinz B Int J Mol Sci. 2024; 25(16).

PMID: 39201399 PMC: 11354465. DOI: 10.3390/ijms25168712.

References
1.
Macrin D, Joseph J, Pillai A, Devi A . Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence. Stem Cell Rev Rep. 2017; 13(6):741-756. DOI: 10.1007/s12015-017-9759-8. View

2.
Meng H, Lu V, Khan W . Adipose Tissue-Derived Mesenchymal Stem Cells as a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis. Pharmaceuticals (Basel). 2021; 14(12). PMC: 8705514. DOI: 10.3390/ph14121280. View

3.
Si Z, Wang X, Sun C, Kang Y, Xu J, Wang X . Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother. 2019; 114:108765. DOI: 10.1016/j.biopha.2019.108765. View

4.
Liu X, Xiang Q, Xu F, Huang J, Yu N, Zhang Q . Single-cell RNA-seq of cultured human adipose-derived mesenchymal stem cells. Sci Data. 2019; 6:190031. PMC: 6390702. DOI: 10.1038/sdata.2019.31. View

5.
Ilicic T, Kim J, Kolodziejczyk A, Bagger F, McCarthy D, Marioni J . Classification of low quality cells from single-cell RNA-seq data. Genome Biol. 2016; 17:29. PMC: 4758103. DOI: 10.1186/s13059-016-0888-1. View